SPX3,825.33+39.95 1.06%
DIA310.85+3.03 0.98%
IXIC11,127.85+99.11 0.90%

BRIEF-Pardes Biosciences Says FDA Granted Fast Track Designation For PBI-0451

reuters.com · 06/09/2022 06:10
BRIEF-Pardes Biosciences Says FDA Granted Fast Track Designation For PBI-0451

- Pardes Biosciences Inc PRDS:

  • PARDES BIOSCIENCES INC - ON JUNE 6, FDA GRANTED FAST TRACK DESIGNATION FOR PBI-0451

  • PARDES BIOSCIENCES - SEES ENROLLING GLOBAL, PLACEBO-CONTROLLED PHASE 2 CLINICAL TRIAL IN VACCINATED/UNVACCINATED PARTICIPANTS WITH MILD-TO-MODERATE COVID-19 LATER THIS YEAR

  • PARDES BIOSCIENCES - ANTICIPATES GENERATING DATA FROM PHASE 3 REGISTRATIONAL TRIALS IN 2023

Source text for Eikon: [https://bit.ly/3aS4irp]

Further company coverage: PRDS


((Reuters.Briefs@thomsonreuters.com;))